Clopido 75mg Tablets is primarily indicated in conditions like Atherosclerosis, Myocardial infarction, Myocardial infarction prophylaxis, Peripheral arterial disease, Prophylaxis for NSAIDassociated gastric and duodenal ulcers, Stroke, Stroke prophylaxis, Thrombo-embolic complications, and can also be given in adjunctive therapy as an alternative drug of choice in Angina, Unstable angina.
Clopido 75mg Tablets is contraindicated in conditions like Peptic ulcer, Intracranial hemorrhage, Hypersensitivity.
The severe or irreversible adverse effects of Clopido 75mg Tablets , which give rise to further complications include Hepatitis, Oedema. The signs and symptoms that are produced after the acute overdosage of Clopido 75mg Tablets include BLood dyscrasias. The symptomatic adverse reactions produced by Clopido 75mg Tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Nausea, Diarrhea, Abdominal pain, Rashes, Skin RashX, Dyspepsia, Depression, Arthralgia, Influenza like syndrome, Chest pain, GI disturbance, Epistaxis.
Use with caution in patients recieving other drugs that increase risk of bleeding including anticogulants platelets and NSAIDS. It should be used with extreme caution in patients with history of bleeding disorder, or who may be at risk of increased bleeding from trauma, Surgery or other pathalogical conditions, and patients with ulcers, liver problems or low blood count. If a patient is to undergo elective Surgery and an antiplatelet effect is not desired, Clopido 75mg Tablets should be discontinued 7 days prior to surgery. It is classified as pregnancy category B and should be used with caution during pregnancy or lactation.